Track Dr Agarwals Eye Hospital Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 5.48 %
Low
4,936.4
High
5,499.0
1 Month returns: 5.70 %
Low
4,813.5
High
5,499.0
1 Year returns: 21.07 %
Low
4,231.0
High
6,392.0
3 Year CAGR: 44.13 %
Low
1,710.1
High
7,300.0
5 Year CAGR: 66.54 %
Low
380.7
High
7,300.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Dr Agarwals Eye Hospital Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Dr Agarwals Eye Hospital Ltd. Shareholding Pattern
Quarterly breakdown of Dr Agarwals Eye Hospital Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Dr Agarwals Eye Hospital Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Dr Agarwals Eye Hospital Ltd.?
The current share price of Dr Agarwals Eye Hospital Ltd. is ₹ 5,285.00 as of 7 Aug 2026.
What is the market capitalisation of Dr Agarwals Eye Hospital Ltd.?
The market capitalisation of Dr Agarwals Eye Hospital Ltd. stands at ₹ 2,483.95 Cr.
What is the PE ratio of Dr Agarwals Eye Hospital Ltd.?
The Price-to-Earnings (PE) ratio of Dr Agarwals Eye Hospital Ltd. is 32.59 as of the latest trailing twelve months data.
What is the ROE and ROCE of Dr Agarwals Eye Hospital Ltd.?
Dr Agarwals Eye Hospital Ltd. has a Return on Equity (ROE) of 25.22% and a Return on Capital Employed (ROCE) of 16.40% as per the latest financial reports.
What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd.?
The 52-week high of Dr Agarwals Eye Hospital Ltd. is - and the 52-week low is -.
What is the dividend yield of Dr Agarwals Eye Hospital Ltd.?
The dividend yield of Dr Agarwals Eye Hospital Ltd. is 0.13% based on the current market price.
What is the FII and DII holding in Dr Agarwals Eye Hospital Ltd.?
Foreign Institutional Investors (FII) hold 2.24%, Domestic Institutional Investors (DII) hold 0.03% and retail/public investors hold 21.97% of Dr Agarwals Eye Hospital Ltd. shares.
What sector does Dr Agarwals Eye Hospital Ltd. belong to?
Dr Agarwals Eye Hospital Ltd. operates in the Healthcare sector.
What is the beta of Dr Agarwals Eye Hospital Ltd.?
The beta of Dr Agarwals Eye Hospital Ltd. is 0.38, indicating its price volatility relative to the broader market. Over the past 1 year, Dr Agarwals Eye Hospital Ltd. has delivered an absolute return of 18.09%.
What is the RSI of Dr Agarwals Eye Hospital Ltd.?
The 14-day Relative Strength Index (RSI) of Dr Agarwals Eye Hospital Ltd. is 67.19, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Dr Agarwals Eye Hospital Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 71.2 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
71.2 / 100
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 3.19% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
High and stable operating margin
The company reported strong operating margin of 21.11% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 81 bps from 1 year ago
What is Operating profit margin?
Strong revenue growth and in line with median growth of industry
The company delivered strong revenue growth of 20.01% for 12-month ended 30 Jun 2026 and the growth was 1.71 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 18.3
Value 20.01
10.9260.59
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 29.09% for 12-month ended 30 Jun 2026 and the growth was 24.24 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low and declining Debt to Equity
The company has low Debt to Equity of 0.94 as on 30 Jun 2026 and Debt to Equity decreased by 0.65 in the last 1 year
What is Debt to Equity?
Company's earnings are of high quality
Earnings quality score of 72.5 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
72.5 / 100
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Negative
Low dividend yield
The company has a low dividend yield of 0.13%
What is Dividend yield?
Neutral
Stock appears expensive but is at a discount to industry median P/E
PE TTM of 32.59 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -34.4%
What is P/E Ratio?
Median: 49.68
Value 32.59
12.393073.36
High ROE but declining trend
The company reported strong ROE of 25.22% for 12-month ended 30 Jun 2026 but ROE declined by -457 bps from 1 year ago
What is ROE (FY)?
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
5,285.0030.0 (0.57%)
20.11% in past 1 year
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Index Presence
Dr Agarwals Eye Hospital Ltd. is not part of any tracked index.
History of Dr Agarwals Eye Hospital Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 3/share
Record date: 7th Nov 2025Ex-date: 7th Nov 2025
Announced on: 27th Oct 2025
Dividend₹ 3.50/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 28th May 2025
Dividend₹ 2.50/share
Record date: 8th Nov 2024Ex-date: 8th Nov 2024
Announced on: 24th Oct 2024
Dividend₹ 2.50/share
Record date: 19th Aug 2024Ex-date: 19th Aug 2024
Announced on: 25th Apr 2024
Dividend₹ 2.50/share
Record date: 31st Oct 2023Ex-date: 31st Oct 2023
Announced on: 13th Oct 2023
Company Profile
Overview of Dr Agarwals Eye Hospital Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Dr. Agarwals Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
Dr. Agarwals Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, ...
Key personnel
Mr. Yashwanth Venkat
Interim Chief Financial Officer
Mrs. Meenakshi Jayaraman
Compliance Officer, Company Secretary
Mrs. Saradha Govindarajan
Compliance Officer
Mr. S. Lakshmi Narasimhan
Company Secretary
Dr. Amar AgarwalD
Executive and Non-Independent Chairman of the Board, Managing Director